2,2'-(9,9-Dihexyl-9H-fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 100mg

Dimethyl 3-Nitrophthalate>99.0%(GC)5g

Objectif E-plan EPLi 10x/0.25 IOS corrigé à l'infini

Ethyl 2-(3-aminooxetan-3-yl)acetate, 95.0%, 5g

2-BROMO-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBALDEHYDE, 95.0%, 1g

2-(4-Dimethylaminophenyl)-1,3-thiazole-4-carboxylic acid, 95.0%, 1g

METHYL 3,4-DIHYDROXY-2-METHYLBENZOATE, 95.0%, 5g

Molybdate de sodium dihydraté 99 +% pur 2,5 kilogramme

4-(4-tert-butylbenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

1-Piperazinecarboxylic acid, 4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-2-[[(1,1-dimethylethyl)amino]carbonyl]-, phenylmethyl ester, (2S)-, 97%, 100mg

6-Fluoroquinazolin-4(3H)-one, 95.0%, 25g

(E)-4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenol, 1g

2,2,2-Trifluoroethyl n-(2-fluorophenyl)carbamate, 97%, 100mg